Peter Olson
- Cancer Research top 0.5%
- Cancer Genomics and Diagnostics 5
- Oncology top 0.5%
- Pancreatic and Hepatic Oncology Research 9
- Cancer Immunotherapy and Biomarkers 5
- Cancer Cells and Metastasis 5
- Molecular Biology top 1%
- Peroxisome Proliferator-Activated Receptors 8
- Metabolism, Diabetes, and Cancer 5
- Cancer-related gene regulation 5
- Physiology top 1%
- Immunology top 2%
-
- Urologic and reproductive health conditions 5
- Co-authors
- Douglas HanahanRonald M. EvansMorgan TruittNeta ErezChih‐Hao LeeJerrold M. OlefskyAndrea L. HevenerJamie Le
- Journals
- Cancer Research (10 papers)Molecular Cancer Therapeutics (7 papers)Proceedings of the National Academy of Sciences (6 papers)
- Partner nations
- United StatesFranceIsrael
In The Last Decade
Peter Olson
83 papers receiving 8.1k citations
Hit Papers
Peers
Comparison fields: 5 of 125
- Cancer Research 1.9k
- Oncology 3.3k
- Molecular Biology 4.4k
- Physiology 1.4k
- Immunology 1.1k
Countries citing papers authored by Peter Olson
This map shows the geographic impact of Peter Olson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Olson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Olson more than expected).
Fields of papers citing papers by Peter Olson
This network shows the impact of papers produced by Peter Olson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Olson. The network helps show where Peter Olson may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Peter Olson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 0 | |
| 2 | 2023 | 33 | |
| 3 | 2023 | 20 | |
| 4 | 2023 | 0 | |
| 5 | 2022 | 78 | |
| 6 | 2021 | 109 | |
| 7 | 2018 | 9 | |
| 8 | 2017 | 60 | |
| 9 | Bruton Tyrosine Kinase–Dependent Immune Cell Cross-talk Drives Pancreas Cancerbreakdown → | 2015 | 381 |
| 10 | 2015 | 122 | |
| 11 | 2014 | 34 | |
| 12 | 2009 | 222 | |
| 13 | 2007 | 103 | |
| 14 | 2006 | 402 | |
| 15 | Smad4 is dispensable for normal pancreas development yet critical in progression and tumor biology of pancreas cancerbreakdown → | 2006 | 506 |
| 16 | 2003 | 25 | |
| 17 | Minireview: Lipid Metabolism, Metabolic Diseases, and Peroxisome Proliferator-Activated Receptorsbreakdown → | 2003 | 742 |
| 18 | 2001 | 90 | |
| 19 | 2000 | 12 | |
| 20 | 1997 | 2 |
About Peter Olson
Peter Olson is a scholar working on Oncology, Transplantation and Cancer Research, having authored 86 papers that have together received 8.3k indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (9 papers), Peroxisome Proliferator-Activated Receptors (8 papers), Cancer Genomics and Diagnostics (5 papers), Metabolism, Diabetes, and Cancer (5 papers), Cancer Immunotherapy and Biomarkers (5 papers), Urologic and reproductive health conditions (5 papers), Cancer Cells and Metastasis (5 papers) and Cancer-related gene regulation (5 papers). The work is most often cited by research in Cancer Research (1.9k citations), Oncology (3.3k citations) and Molecular Biology (4.4k citations). Peter Olson has collaborated with scholars based in United States, France and Israel. Frequent co-authors include Douglas Hanahan, Ronald M. Evans, Morgan Truitt, Neta Erez, Chih‐Hao Lee, Jerrold M. Olefsky, Andrea L. Hevener, Jamie Le, Yaacov Barak and Michael C. Nelson. Their work appears in journals such as Cancer Research, Molecular Cancer Therapeutics, Proceedings of the National Academy of Sciences, Diagnostic Cytopathology and Archives of Pathology & Laboratory Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.